VTAK Catheter Precision, Inc.: institutional ownership and insider trading
11 funds reported holding $85.9K of Catheter Precision, Inc. in their latest 13F filings; in Q2 2026 funds net sold $29.4K, with 1 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $1.92M and net income of −$13.0M.
VTAK revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.02M, net income −$3.30M
- Quarter ended Mar 31, 2026: revenue $432K, net income −$1.68M
- Quarter ended Dec 31, 2025: revenue $238K, net income −$5.78M
- Quarter ended Sep 30, 2025: revenue $226K, net income −$2.25M
Largest institutional holders of VTAK
- VANGUARD GROUP INC — $28.7K
- Virtu Financial LLC — $17.0K
- UBS Group AG (UBS) — $14.5K
- GEODE CAPITAL MANAGEMENT, LLC — $10.2K
- Tower Research Capital LLC (TRC) — $8.03K
- OSAIC HOLDINGS, INC. — $7.26K
- Allworth Financial LP — $255
- CITIGROUP INC (C, C-PN) — $19
- Purpose Unlimited Inc. — $9
- HARBOUR INVESTMENTS, INC. — $7
Recent VTAK insider trades
- Jan 29, 2025: Colombatto Martin J sold 3 shares ($1)
5%+ owners
- C/M Capital Partners, LP: 10.0% (Schedule 13G, filed Aug 21, 2026)
- SEG JETS SPV I, LLC: 9.8% (Schedule 13G, filed Jul 20, 2026)
Who owns the most VTAK stock?
The largest institutional holders of Catheter Precision, Inc. in the latest 13F filings are VANGUARD GROUP INC ($28.7K), Virtu Financial LLC ($17.0K), UBS Group AG (UBS) ($14.5K).
Are insiders buying or selling VTAK?
No open-market insider buys or sells of Catheter Precision, Inc. were reported in the last 12 months.
What was VTAK's revenue last quarter?
Catheter Precision, Inc. reported revenue of $1.02M for the quarter ended June 30, 2026, with net income of −$3.30M.